The Full-Court Press: How BIG3 is Tackling Prostate Cancer Disparities

LOS ANGELES, CA – June 16, 2026

In arenas across America this summer, the fast-paced action of 3-on-3 basketball will be accompanied by a message of life-or-death urgency. The BIG3, the professional league co-founded by cultural icon Ice Cube, has joined forces with the Prostate Cancer Foundation (PCF) in a groundbreaking partnership. Their goal: to turn courtside entertainment into a powerful platform for health intervention, directly confronting the stark racial disparities in prostate cancer outcomes through the “Check the Box! Saving Lives Together” initiative.

This isn't a typical celebrity endorsement. The collaboration represents an innovative model for public health, leveraging the deep cultural connection between a sports league and its core audience to deliver a critical, life-saving message. With a fanbase that heavily includes Black men over 40—the population at the highest risk—the BIG3 is uniquely positioned to drive change where it's needed most.

“In this game — and in this community — we protect each other,” said Ice Cube, co-founder of the BIG3. “The BIG3 is 3-on-3 basketball — three players, one goal: win. ‘Check the Box!’ works the same way. Three steps, one goal: save your life. Talk to your doctor. Take the blood test. Learn your score. That’s it. That’s the play. Make it.”

A Matter of Equity: Confronting a Silent Crisis

The urgency behind this partnership is rooted in alarming statistics that paint a picture of a profound health crisis. For Black men in the United States, prostate cancer is not just a risk; it's a disproportionate threat. According to extensive research from organizations like the National Cancer Institute, Black men are approximately 1.7 times more likely to be diagnosed with prostate cancer than their white counterparts and are over twice as likely to die from the disease.

This disparity goes beyond mere incidence. Black men are often diagnosed at a younger age and with more aggressive forms of the cancer, leading to more challenging prognoses. The reasons for this inequity are complex and multifactorial, weaving together a troubling narrative of systemic barriers and biological predispositions. While emerging research points to potential genetic factors that may make prostate cancer in Black men biologically distinct, public health experts stress that social and systemic factors play a massive, undeniable role. These include reduced access to high-quality healthcare, implicit bias in medical settings where Black men may be less likely to be offered screening, and a deep-seated, historically justified mistrust of the healthcare system.

The PCF-BIG3 alliance aims to cut through these barriers by meeting men where they are, in a setting built on community and trust. “This partnership is about turning the power of community into the power to save lives,” said Gina Carithers, President and CEO of the Prostate Cancer Foundation. “The BIG3 reaches men in a space built on trust, pride, and connection—and that’s exactly where change begins.”

Beyond Awareness: Bringing Screening Courtside

For decades, public health campaigns have focused on raising awareness. The “Check the Box!” initiative takes a crucial step further by moving from awareness to direct action. Throughout the BIG3’s 10-week national tour, the campaign will not only feature public service announcements with league legends like Commissioner Clyde Drexler but will also deploy free, on-site prostate cancer screening booths at games.

This strategy is a direct-to-consumer innovation in preventative health, dismantling common barriers to screening such as cost, inconvenience, and lack of access. The screening itself involves a simple Prostate-Specific Antigen (PSA) blood test. While the utility of routine PSA screening for the general population has been a subject of medical debate due to risks of overdiagnosis and overtreatment, there is a strong consensus on the importance of targeted screening for high-risk groups.

The American Cancer Society recommends that Black men begin conversations with their doctors about screening at age 45, or even 40 for those with a strong family history. The PCF advocates for these conversations to start at age 40. The BIG3 partnership is a real-world application of this tailored guidance, focusing resources and messaging on the very demographic that stands to benefit most from early detection. When caught in its early, localized stages, prostate cancer has a 5-year survival rate of nearly 100%. The gap between that hopeful statistic and the grim reality for many Black men is precisely what this initiative seeks to close.

By providing screenings on-site, the program addresses the critical next step after awareness is raised, creating a seamless path from education to action. It offers a tangible solution in an environment where men may feel more comfortable and receptive.

The New Playbook for Public Health

The collaboration signals a larger shift in how industries can address societal challenges. It leverages the platform and cultural capital of sports and entertainment not just for promotion, but for tangible community impact. The voices of trusted figures like Ice Cube, Clyde Drexler, and coaches like Naismith Hall of Famer Nancy Lieberman carry a weight that traditional health messaging often lacks.

“Getting tested isn’t just about you – it’s about your family and your future,” said Lieberman, Coach of Dallas Power. “Early detection saves lives. Through the BIG3 basketball league and the Prostate Cancer Foundation, we’re urging men to take control and get screened.”

By embedding a critical health service within a popular cultural event, the PCF and BIG3 are creating a new playbook for preventative medicine. It’s a model that acknowledges the importance of trust, access, and cultural relevance in overcoming long-standing health disparities. As the BIG3 season unfolds in cities from Houston to Detroit, the most important victory may not be the one that happens on the court, but the one that begins with a simple conversation and a life-saving blood test.